There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with ...
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
ACAPELLA is the European multicenter clinical trial evaluating Alpha DaRT alpha-emitter radiotherapeutics combined with capecitabine for ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by ...
Tumor reponse, biomarker, and subgroup analyses from the VIRAGE Phase 2b clinical trial support a VCN-01 immune-mediated mode of action and ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Unlike organs like the liver or the heart, the pancreas plays a more subtle yet important role in a wide ...
Results are in from an early trial of an MRNA-based vaccine to fight pancreatic cancer.
Theriva Biologics to present additional data from VIRAGE phase 2b trial of VCN-01 in metastatic pancreatic cancer at AACR 2026 meeting: Rockville, Maryland Monday, April 20, 2026, ...
Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by ...
Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic ...
We are once again proud to join the Lustgarten Foundation in raising awareness and funds for critical pancreatic cancer research. CBS News New York's Jenna DeAngelis served as emcee of the annual walk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results